Faculty Advisor(s)

Elisha Coppens

Document Type


Publication Date



© 2023 The Author


Spinal anesthesia is the preferred route of anesthesia for parturients undergoing casesarean section (Hawkins et al., 2011). Parturients with obesity undergo caesarean delivery and have higher rates of initial intrathecal failure comparatively to non-obese (Hood, et al, 2015). Obesity is on the rise leading to a reconsideration as to the dosing of spinal anesthetic type (Dennis, 2017). Historically, the utilization of ondansetron, as a selective 5-HT3 antagonist, has been utilized prior to spinal administration to prevent the sympathectomy that can occur (Sahoo et al., 2012). This has decreased the utilization of vasopressors which can be detrimental to the fetus during cesarean (Kinsella et al., 2017).

A literature search was performed using major databases. 30 articles experimental studies, randomized control trials (RCT) and systematic reviews of RCTs with or without meta-analysis published within the last ten years were selected for initial review. 17 articles were identified as related to obesity and pregnancy undergoing spinal anesthesia for cesarean section.

Ondansetron’s utilization as an effective attenuator of a subarachnoid block sympathectomy has been accepted through various studies. However, through the literature review, a gap in obesity with dosing of prophylactic 5-HT3 antagonists and intrathecal local anesthetics, as well as, objective non-invasive data collecting to facilitate spinal anesthetic hypotension from occurring.


MSNA Capstone



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.